<?xml version="1.0" encoding="UTF-8"?>
<title>We test asymptomatic patients for SARS-CoV-2 infection by nasopharyngeal swab RT-PCR 72-24â€Šhours before starting CLL therapy. During treatment, patients are questioned for clinical manifestations consistent with COVID-19, including atypical symptoms, over the phone or at the clinic's door</title>
